Response assessment at different time points and best recorded response per patient
| Objective response . | n (%) . | |||
|---|---|---|---|---|
| After 4 cycles of induction . | After 2 cycles of consolidation∗ . | Before start of maintenance . | Best response . | |
| Response categories | ||||
| Stringent CR | 0 | 0 | 0 | 0 |
| CR | 0 | 3 (12.5) | 5 (20.8) | 10 (41.7) |
| VGPR | 12 (50.0) | 15 (62.5) | 13 (54.2) | 10 (41.7) |
| Partial response | 10 (41.7) | 1 (4.2) | 1 (4.2) | 4 (16.7) |
| Minimal response | 1 (4.2) | 0 | 0 | 0 |
| Stable disease | 1 (4.2) | 0 | 0 | 0 |
| Progressive disease | 0 | 0 | 0 | 0 |
| Not evaluated | 0 | 5 (20.8) | 5 (20.8) | 0 |
| Objective response rate | 95.6% | 79.2% | 79.2% | 100% |
| Objective response . | n (%) . | |||
|---|---|---|---|---|
| After 4 cycles of induction . | After 2 cycles of consolidation∗ . | Before start of maintenance . | Best response . | |
| Response categories | ||||
| Stringent CR | 0 | 0 | 0 | 0 |
| CR | 0 | 3 (12.5) | 5 (20.8) | 10 (41.7) |
| VGPR | 12 (50.0) | 15 (62.5) | 13 (54.2) | 10 (41.7) |
| Partial response | 10 (41.7) | 1 (4.2) | 1 (4.2) | 4 (16.7) |
| Minimal response | 1 (4.2) | 0 | 0 | 0 |
| Stable disease | 1 (4.2) | 0 | 0 | 0 |
| Progressive disease | 0 | 0 | 0 | 0 |
| Not evaluated | 0 | 5 (20.8) | 5 (20.8) | 0 |
| Objective response rate | 95.6% | 79.2% | 79.2% | 100% |
Primary end point.